default author photo

Laura Fontana

Department of Medical-Surgical Physiopathology and Transplantation, Università degli Studi di Milano

United States

SCHOLARLY PAPERS

1

DOWNLOADS

145

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Serum Sphingosine-1-Phosphate as Novel Prognostic and Predictive Biomarker for COVID-19 Severity and Morbidity and Its Implications in Clinical Management

Number of pages: 29 Posted: 30 Aug 2020
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Laboratory of Experimental Neurosurgery and Cell Therapy, Laboratory of Experimental Neurosurgery and Cell Therapy, Neurosurgery Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Laboratory of Experimental Neurosurgery and Cell Therapy, Neurosurgery Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Laboratory of Experimental Neurosurgery and Cell Therapy, Neurosurgery Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan - Respiratory Unit, Laboratory of Experimental Neurosurgery and Cell Therapy, Neurosurgery Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Laboratory of Clinical Biochemistry, ASST Santi Paolo e Carlo,Department of Health Sciences, Università degli Studi di Milano, Department of Medical-Surgical Physiopathology and Transplantation, Università degli Studi di Milano, Istituto di Medicina Aerospaziale "A. Mosso", Aeronautica Militare, viale dell’Aviazione, Department of Medical-Surgical Physiopathology and Transplantation, Università degli Studi di Milano, Istituto di Medicina Aerospaziale "A. Mosso", Aeronautica Militare, SC Anestesia e Rianimazione, ASST Santi Paolo e Carlo, Reproductive Medicine Unit, ASST Santi Paolo e Carlo, Università degli Studi di Milano, Respiratory Unit, ASST Santi Paolo e Carlo, San Paolo Hospital, Department of Health Sciences, Università degli Studi di Milano and University of Milan
Downloads 145 (508,926)

Abstract:

Loading...

COVID-19, Coronavirus, SARS-CoV-2, sphingosine-1-phosphate, biomarkers, Intensive Care Unit, apolipoprotein M, clinical management